KAMURARepair & inflammation / VISUAL FIELD GUIDE
LL-37
LL-37 is part of innate immune defence. Its antimicrobial biology and wound studies do not make it a general treatment for recurrent infections.
01 / FOLLOW THE BIOLOGY
From signal to response.
Schematic explanation · not a measured treatment response
STEP 1 OF 3
Innate defence
The body uses antimicrobial peptides at barriers.
Pathway sources: [1]
What are you trying to understand?
Choose a concern to see the research context. A symptom is a starting point for assessment, not a treatment selection.
Human topical research
Hard-to-heal wounds
Topical LL-37 has been studied with compression therapy in venous leg ulcers; interpretation must use that setting and trial results.
Examine the supporting research ↓The details that change the interpretation.
Formulation & route
Topical wound formulations and systemic LL-37 are not equivalent.
Bring to the discussion
What did the whole trial show, and was the person’s wound type represented?